Literature DB >> 6405199

The complete amino acid sequence of the light chain variable region of two monoclonal anti-p-azobenzene-arsonate antibodies bearing the cross-reactive idiotype.

R K Ball, J Y Chang, S S Alkan, D G Braun.   

Abstract

Two monoclonal anti-p-azobenzene-arsonate antibodies produced by cell fusion of A/J spleen lymphocytes were selected. It had previously been shown that they both expressed the cross-reactive idiotype (CRI) and that the amino terminal sequence of their heavy chain variable region differed by only one amino acid substitution within the first 55 residues, at residue 41 in the second framework region. A novel, sensitive peptide-mapping method had indicated that the light chain of these two antibodies differed by at least three amino acid substitutions. Here, the complete amino acid sequence of the light chain variable region is presented. There are only 3 amino acid substitutions between the two antibodies, located in the first and second complementarity determining regions and the third framework region respectively. Although the variable region of the light chains of these two monoclonal antibodies show such a high degree of homology they differ by 26 and 27 substitutions from the reference sequence of the light chain of CRI+ anti-ABA serum antibodies. In addition, they are homologous to 4 other such CRI+ monoclonal antibody light chain sequences published so far, in which only 2 of the above 3 substitutions are not represented. The contribution of the light chain to the CRI is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405199     DOI: 10.1016/0161-5890(83)90131-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  Identity of the V kappa 10-Ars-A gene segments of the A/J and BALB/c strains.

Authors:  K Meek; I Sanz; G Rathbun; A Nisonoff; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  Relationship of VH and VL genes encoding three idiotypic families of anti-p-azobenzenearsonate antibodies.

Authors:  P F Robbins; E M Rosen; S Haba; A Nisonoff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Somatic evolution of variable region structures during an immune response.

Authors:  L Wysocki; T Manser; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  Isolation of hybridomas expressing a specific heavy chain variable region gene segment by using a screening technique that detects mRNA sequences in whole cell lysates.

Authors:  T Manser; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Structural correlates of high antibody affinity: three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold.

Authors:  J Sharon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Single germline VH and V kappa genes encode predominating antibody variable regions elicited in strain A mice by immunization with p-azophenylarsonate.

Authors:  L J Wysocki; T Gridley; S Huang; A G Grandea; M L Gefter
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

7.  Primary structure of IgE monoclonal antibodies expressing an intrastrain crossreactive idiotype.

Authors:  S Haba; E M Rosen; K Meek; A Nisonoff
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

8.  Structural characterization of antiidiotypic antibodies. Evidence that Ab2s are derived from the germline differently than Ab1s.

Authors:  K Meek; C Hasemann; B Pollok; S S Alkan; M Brait; M Slaoui; J Urbain; J D Capra
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

9.  Amino acid sequence diversity within the family of antibodies bearing the major antiarsonate cross-reactive idiotype of the A strain mouse.

Authors:  C A Slaughter; J D Capra
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.